AMERIPRISE FINANCIAL INC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,322,713
-22.5%
198,011
-2.7%
0.00%
-100.0%
Q2 2023$1,706,853
+19.8%
203,439
+41.8%
0.00%
Q1 2023$1,424,279
+45.9%
143,432
+2.3%
0.00%
Q4 2022$976,000
+378.4%
140,232
+267.1%
0.00%
Q3 2022$204,000
+110.3%
38,200
+57.9%
0.00%
Q2 2022$97,000
-29.2%
24,200
-21.4%
0.00%
Q1 2022$137,000
+11.4%
30,8000.0%0.00%
Q4 2021$123,000
-69.5%
30,800
-32.9%
0.00%
Q3 2021$403,000
-21.0%
45,900
-0.2%
0.00%
Q2 2021$510,000
+79.6%
46,000
+92.5%
0.00%
Q1 2021$284,000
-73.7%
23,900
-84.8%
0.00%
Q4 2020$1,081,000
-38.4%
157,558
-33.4%
0.00%
-100.0%
Q3 2020$1,754,000
+2207.9%
236,674
+1182.6%
0.00%
Q2 2020$76,000
-91.4%
18,453
-82.6%
0.00%
Q4 2018$879,000
-23.2%
105,967
+27.9%
0.00%
Q3 2018$1,144,00082,8820.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders